Objectives: This study aims to characterize the relationships between the quality of the information given by the physician, the involvement of the patient in shared decision making (SDM), and outcomes in terms of satisfaction and anxiety pertaining to the treatment of inflammatory bowel disease (IBD).
Introduction
Patient involvement in shared treatment decision making has been associated with increased patient satisfaction, improved medication adherence and better health outcomes in primary care settings [1] . These outcomes are especially relevant in the context of chronic illness, where several treatment adjustments and/or modifications occur over time, within a long-term relationship between the patient and his/her medical specialist [2] [3] [4] . The complexity of shared treatment decision making increases the difficulty of process assessment. Furthermore, no single metric reflecting informed treatment decision making exists [5] . In this regard, most attempts to evaluate informed treatment decision making have assessed knowledge, screening intention, and behaviour. However, Johansson [6] has reported that patient involvement in treatment decisions has rarely been discussed. This process could have a significant impact on a patient's future psychological well-being and health outcomes.
The present study was aimed at investigating how elements of patient involvement in shared decision making (SDM) may influence both satisfaction with treatment or anxiety concerning the medical experience, resulting in a model of SDM for the specific context of inflammatory bowel disease (IBD) patients.
Information transfer between the physician and the patient
Shared treatment decision making relies on the quality of the information given by the physician to the patient. According to Brédart, Bouleuc, and Dolbeault [7] , a medical interview is successful if communicative behaviours follow both the patient's agenda with his symptoms, preferences and concerns and the doctor's agenda with details of disease and treatment options. This exchange consists of "information seeking" and "information giving" from both the physician and the patient. Previous studies have shown that a lack of information may actually interfere with a successful choice made by the patient [8] . For instance, patients with irritable bowel syndrome primarily expected comprehensive information, references to sources of additional information, answers to their questions, an attentive ear, and information about studies on disease and medication from their health care providers [9] . Information provided by physicians requires an initial clarification of the patients' needs for information or values [10, 11] . If the information provided by the physician meets the patient's need for information, a relationship of trust will be fostered with the treating physician. Specifically, when physicians fulfill the information needs of their patients in terms of treatment options and management of medications, confidence in the treating physician will strengthen and promote patient's involvement in decisions to increase adherence to treatment [3, [12] [13] [14] [15] .
Patients with IBD are likely to experience several treatment changes in accordance with their disease progression and the emergence of new treatments, which requires an ongoing transfer of information throughout the patient's life. The need for a high quality information transfer could be even more important in these conditions than for diseases such as cancer, which have been the principal focus of current research on this matter.
Accordingly, the present study proposes that the quality of the information transfer influences patient involvement in SDM (first hypothesis -H1; see Table 1 ).
Shared decision-making process
The most-often used definition of SDM was proposed by Charles et al. [16] and is characterized by the following elements: "(1) that at least two participants -physician and patient -be involved; (2) that both parties share information; (3) that both parties take steps to build a consensus about the preferred treatment; and (4) that an agreement is reached on the treatment to implement". Consistent with this definition and current literature, this study suggests that SDM starts with a high quality information transfer between the doctor and the patient, is followed by an understanding of this information by the patient, and then by his involvement in treatment selection and his certainty over this choice. Patients' understanding of the information given by their physicians is a crucial first step in SDM. Patients who receive information are more likely to report optimal satisfaction with pain medication than those who do not, and patients who participate in SDM are also more likely to report optimal satisfaction with treatment and display a greater average decrease in pain score [1] . A number of studies have shown that patients prefer situations where physicians present to them a range of treatment options, as they want to understand the reasons for which they may need a specific medication as opposed to another [17, 18] . Thus, the quality of the physician-patient information transfer is linked to information comprehension by patients as well as their involvement in SDM. Furthermore, such studies have identified low levels of information understanding as a factor involved in treatment adherence: patients whose physicians prescribe a medication without explaining the reasons behind his/her choice or sideeffects were significantly associated with a low adherence during the first year of treatment. Thus, physicians must be aware of patient's preferences towards the administration and dosing of their medications in order to help guide their treatment decisions [19] .
Perceived levels of certainty over the chosen treatment option influences levels of involvement by the patients. Ramfelt and Lützén [20] actually suggest that compliance with participation was characterized by open dialogue between the physician and the patient. However, compliance without participation has been associated with participants' feelings of uncertainty and distress, and of being rushed into the subject of decisions, without having time to properly reflect on the information provided or the opportunity to influence the treatment and care process. Carter, Lobo, and Travis [21] propose that individuals with IBD strongly believe that they need sufficient information in order to make a rational personal choice about treatment options. According to McCormack et al. and satisfaction with treatment decisions [22] . Considering the interconnection between information comprehension, patient involvement and decision certainty, three components of SDM, the present study proposes that the first component influences the second which, in turn, influences the third (H2; Table 1 ).
Satisfaction
Patients' satisfaction levels reflect the extent to which the patients' healthcare needs, expectations and preferences are met. Janisse [23] has indicated that physicians whose patients were the most satisfied described a need to listen to their patients sufficiently for them to feel understood by the patients, and for the patients to then feel understood in return, such that the explanations sought by the patients can generate mutual trust and understanding. King and Hoppe [24] have reported that patient satisfaction is strongly associated with the communication behaviors that occur during the physician-patient interactions. By drawing out patients with active listening responses, physicians gather information to understand the patients' needs for their current meeting. Subsequently, physicians had to actively provide information to meet their patients' needs and overcome barriers to patient understanding, such as the use of a "biomedical language" or healthcare literacy. Tallman et al. [17] have also observed that physicians with outstanding satisfaction with their patients pertaining to their exchange of information, communicate with their patients by using active listening responses during patient "storytelling". Asking probing questions, especially regarding patients' concerns, give patients the opportunity to express their fears and concerns, and give physicians the opportunity to demonstrate their understanding by responding empathically [25] . Higher physician empathy has been linked to involvement in SDM and lower decision regret [26] . Siegel, et al. [27] have reported that patients were more satisfied when they participated in SDM and dissatisfied patients were skeptical of the medical decision.
Thus, the present study proposes the hypothesis that the three components of SDM may individually influence patient satisfaction (H3; Table 1 ).
Level of anxiety
Patient involvement in SDM regarding their treatment is related to their perceived level of anxiety. According to Pincus, et al. [28] , physicians who provide clear explanations and information improve their patients' emotional reassurance, which in turn increases patient enablement. A systematic review that reported a strong correlation between physician empathy and patient satisfaction also revealed that physician empathy decreases patient anxiety and distress [29] . Thus, patients who receive emotional reassurance from their attending physician or who perceive them as empathetic are less anxious and more satisfied [28, 29] . As such, the present study proposes that both the components of SDM (H4) and satisfaction (H5) influence the level of anxiety experienced by the patient ( Table 1 ).
The objective of this study is to evaluate the impact of the quality of the information transferred by physicians to patients on the SDM process. This study also aims to investigate the influence of SDM on patient satisfaction and anxiety level. Table 1 about here) 2. Methods
Data source and recruitment
The present study is part of a larger Canadian project in inflammatory bowel diseases (IBD), a chronic illness that includes both Ulcerative Colitis (UC) and Crohn's disease (CD). A web survey was selected as a mean to reach as many patients as possible, across Canada. Confidentiality in healthcare networks forbade the authors to directly reach all 233,000 patients who are currently being estimated to be suffering from IBD.
Consequently, the Web survey was broadcasted through the website of the Crohn's and Colitis Canada (CCC), an association that counts 933 members affected by IBD. The web survey was available through the CCC website for 5 months. To ensure we obtained a sufficiently large final sample size, five reminders were posted on the website and in a newsletter as well as on social media (Facebook, Twitter and LinkedIn) via existing CCC platforms. The final sample included 210 adult participants, representing a response rate of 22.5%, which is within the range previously reported in similar studies [30] [31] [32] . From the 210 participants who completed the Web questionnaire, a few respondents did not answer at least one of the questions. The statistical analysis was performed exclusively on a complete set of data for the analyzed variables, which yielded a total of 200 participants.
Variables
The Web survey was based on similar previously published Web surveys [33] [34] [35] . The quality of the transfer of information between the physician and the patient was evaluated as follows: (i) One item measuring patients' level of satisfaction with the information provided by their IBD specialist concerning their last test results. (ii) SDM was evaluated using three items assessing the patients' understanding of the information provided, their level of confidence as to whether the medication prescribed was adequate, and their involvement in the decision with regards to which treatment to pursue. These 3 items were consistent with previous literature on dimensions of shared treatment decision making [16, 36] . (iii) The level of overall satisfaction was measured using one item pertaining to the patients' satisfaction with the suggested treatment process. This item is consistent with current literature on treatment satisfaction among IBD patients [21, 30, 37, 38] . (iv) The patients' anxiety level was measured using one item pertaining to the level of anxiety at the end of the appointment to discuss test results and treatment selection with the IBD specialist. This item was also consistent with current literature on this subject [30, 39] . Likert scales were used in which respondents indicated their agreement or disagreement with a given statement [40] . This type of scale is preferred when measuring complex attitudes or individuals' perception, as this was the case in the present study. According to Preston and Colman [41] , the majority of questionnaires are using scales of 5 or 7.
Even-numbered scales eliminate the respondents' tendency to choose the middle answer, known as central tendency [42] . Therefore, the questionnaire used a scale of 6.
The Web questionnaire was first "pre-tested" by 14 IBD treatment experts, followed by "pre-testing" in 17 patients in a gastroenterology clinic in order to verify their understanding of each question. Minor changes in the wording were subsequently made to complete the final questionnaire.
Analysis
Path analysis was performed using structural equation modelling (SEM). All of the arrows presented in Figure 1 were tested simultaneously and a path coefficient was determined by SEM. In Figure 1 , each variable is given a unique number and each path coefficient tested by SEM is defined as follows: the first subscript stands for direct variable and the second subscript for indirect variable. The CALIS procedure of the SAS/STAT software's capabilities was used with full information maximum likelihood (FIML) as the method of estimation. The usual goodness of fit indices in structural equation modelling were used to determine the model's fit [43] . The strength of the predictor variables was considered statistically significant at p values of less than 0.05.
Results

Response rate and sample characteristics
The statistical study sample included 200 participants with IBD, of whom the demographic profile is described in Table 2 . The majority of the respondents were female (81.0%). The participants were proportionally represented in the three age groups, namely, 18-34 (40.3%), 35-44 (32.7 %), and 45 and over (27.0%). More than half of the respondents were in a conjugal relationship (60.8%). In terms of education, the majority of the respondents held a diploma in vocational or technical training (41.3%) or a university degree (42.9%), while a minority had a high school diploma or less (15.8%).
Most of the respondents considered their health status to be "good or very good" (41.5%) or "okay" (36.5%), and fewer reported their condition to be "very bad or bad" (22.0%).
The questions used from the Web survey along with their statistical analysis are presented in Table 3 . Each question is associated with a variable presented in Figure 1 . Table 2 about here) (Insert Table 3 about here)
(Insert
Path analysis
The theoretical model presented in Figure 1 was adjusted using SAS software and the results are presented below. The correlation coefficients between the variables of the model are also presented in Table 4 . All correlations are positively significant, meaning strong correlations between all of the model's variables. Table 4 
(Insert
Discussion and Conclusion
Discussion
The results of this study confirm that promoting patient involvement in SDM is an endeavour that is worth the investment in time and resources. The quality of the information transfer between the physician and the patient was significantly associated with each factor of the SDM process, thereby validating H1 of our model. Patients must be informed to make complex decisions, especially in cases where treatment options are multiple and with varying risks and benefits. The patients need to understand the myriad of treatment options in order to discuss those options with their physician based on their particular concerns, fears and situation. The quality of the information provided, as well as the bond of trust that is created from listening to the patients' concerns and providing them with adequate information to reassure them about the treatment selection, is particularly crucial in the context of chronic illness [44] . SDM must be perceived as a collaborative process. The long-term relationship built between patients with chronic conditions and their physicians involves multiple treatment selection options, following the patient's signs and symptoms, and the emergence of new treatment options. This long-term interaction fosters a patient's need to seek information and to participate in medical decisions [45] . This result is consistent with previous findings [46, 47] .
It was initially suggested that there might be a linear relationship among the three components of SDM. The correlation between information comprehension and patient involvement was not significant. It is plausible that a correlation does exist between these components, but that it was not strong enough to be significant in the present study. This could mean that quality of information transfer has a direct effect on patient involvement that is not strongly mediated by information comprehension. Thus, quality of information transfer leads to higher patient involvement, which significantly increases decision certainty and satisfaction. Furthermore, quality of information transfer is essential to information comprehension, which in turn leads to higher satisfaction. In the latter case, information comprehension is strictly rational and related to the quality of the information transfer. As reported by Lesnovska, et al. [12] , the acquisition of knowledge is a complex cognitive process that is related to patient health behavior and involves learning, reasoning and communication. Shared decision making includes cognitive limitations and emotional factors mainly in a context where decisions involve technical information, health risks and probabilities that are difficult concepts for inexperienced patients to understand. Decisions about which treatment to pursue are based on more than rational information comprehension about benefits, risks and uncertainty because decisions must align with patient values and preferences [48] . When faced with various treatment options, a patient's application of his or her values and principles can be disrupted by emotions or cognitive interference. Thus, information comprehension is rational, but decision-making involves values, preferences and emotions, which explains the non-significant correlation between information comprehension and patient involvement; they both lead significantly and individually to patient satisfaction.
The patient's involvement in the treatment selection led to higher confidence in the selected treatment option (second part of H2). 'The extent to which the patient's behaviour matches agreed recommendations from the prescriber' along with mutual agreement on treatment decisions refer to adherence [49, 50] . Thus, involvement in treatment selection leads to higher decision certainty about the treatment, which fosters patient's adherence. This finding is consistent with the results of Ramfelt and Lützén [20] , according to which compliance without active involvement in treatment selection was related to a decrease in adherence to treatment. Adherence to treatment is particularly important in a chronic illness such as IBD, in which an interruption in treatment can lead to an irreversible deterioration of the patient's condition.
SDM was significantly associated with patients' satisfaction with their current treatment selection. Each SDM component was significantly correlated with satisfaction, thereby validating H3. Joosten, et al. [45] reported that, in the context of chronic disease where interactions with the physician are extended over time, SDM is often associated with satisfaction, adherence and well-being. Similarly, it has recently been reported that patients with IBD preferred to be involved in SDM and to be well informed. Their participation in SDM was associated with higher satisfaction [27] . The relationships between SDM and the patients' anxiety concerning their current treatment (H4) was not significant, but the three components of SDM have an indirect correlation with anxiety, this correlation being a result of higher satisfaction with the suggested treatment process.
This result is consistent with prior studies suggesting that involvement in SDM may decrease anxiety [51, 52] but, in our proposed model, this decrease in anxiety is observed following an increase in satisfaction. Overall satisfaction leads to a decrease in the level of anxiety concerning the chosen treatment (validating H5). This is consistent with literature on treatment satisfaction among IBD patients [21, 35] . A systematic review has revealed that providing education and explanations, referred to in the literature as cognitive reassurance, result in higher satisfaction and enablement and lower anxiety [28] . Derksen, et al. [29] found that physician empathy increases patient satisfaction which, in turn, decreases patient anxiety and distress.
The present study tested and adjusted an SDM model that results in a linear process through which the quality of information transfer results in a patient's involvement in SDM, which increases the patient's overall satisfaction and subsequently decreases his or her anxiety over the chosen treatment. In addition, a patient's involvement in treatment selection leads to confidence in the treatment that is selected. Lastly, patients' This would also serve to validate or invalidate the absence of any correlation between information comprehension and patient involvement. The non-significance observed here may be due to the absence of correlation, or may be a result of insufficient power to detect the specific correlation. Although future research should also be conducted in order to further characterize, confirm and validate the present findings, such as in a larger and more diversified sample of chronic illnesses, the present study delineates the importance of patient perceptions in IBD as part of the management of their illness.
Conclusion
The present study aimed to investigate how elements pertaining to the participation of patients in SDM may influence both satisfaction with their treatment and the level of anxiety pertaining to their medical experience, in the context of a specific family of chronic illness, namely IBD. The quality of the information transfer between the physician and the chronic patient does influence the involvement of patients in the SDM process. This involvement in SDM is significantly related to patients' satisfaction which, in turn, is related to their level of anxiety over their current treatment, which indirectly correlates SDM to anxiety.
Practice implications
The present results could be useful for both patients and physicians. 
H1
The quality of the information transfer between the physician and the IBD patient will significantly influence the likelihood of patients' involvement in the shared treatment decisionmaking process ( 21 =  31 =  41 ≠ 0).
H2
Comprehension of the information provided by the physician will significantly influence the likelihood of experiencing a high level of involvement in the treatment selection which, in turn, will significantly influence the likelihood of experiencing confidence in the chosen treatment among patients suffering from IBD ( 32 =  43 ≠ 0).
H3
The participation in shared decision-making process will significantly influence the likelihood of experiencing a high level of satisfaction concerning the suggested treatment process in patients suffering from IBD ( 52 =  53 =  54 ≠ 0).
H4
The participation in shared decision-making process will significantly influence the likelihood of experiencing a low level of anxiety concerning the suggested treatment process in patients suffering from IBD ( 62 =  63 =  64 ≠ 0).
H5
The level of patient satisfaction concerning the suggested treatment process will significantly influence the likelihood of experiencing a low level of anxiety concerning the suggested treatment process among patients suffering from IBD ( 65 ≠ 0). 
